Siemens acquires CAD company

Article

In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem,

In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem, Israel, has developed algorithms that detect and classify breast lesions. Siemens may leverage the technology, which is now undergoing clinical validation, across several applications and multiple modalities.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.